|
|
Nabi Biopharmaceuticals - Comparative Business Analysis Snapshot
Business Description
Nabi Biopharmaceuticals. The Group's principal activities are to discover, develop, manufacture and market vaccines and antibody based biopharmaceutical products. The Group operates in two segments: Biopharmaceutical products and Antibody products. The Biopharmaceutical products segment includes the production and sale of proprietary biopharmaceutical products, as well as research and development efforts for the biopharmaceutical product line. The Antibody products segment includes the collection and sale of non-specific and specialty antibody products to other biopharmaceutical manufacturers, as well as the production and sale of antibody-body control and diagnostic products and laboratory testing services. The Group operates in the United States, South Korea, Israel and Canada.
Competitor Analysis
This analysis compares Nabi Biopharmaceuticals with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
